Pharma Dividend Watch: Abbott India, Sun Pharma, Cipla Among 7 Stocks With Upcoming Record Dates

Written by: Kusum KumariUpdated on: 25 May 2026, 5:48 pm IST
Pharma companies including Abbott India, Torrent Pharma, Cipla and Sun Pharma have announced FY26 dividends and record dates. Here are the key details.
Pharma Dividend
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Several pharmaceutical companies are attracting investor attention after announcing dividends for FY26 along with their record dates.

Major pharma firms such as Torrent PharmaceuticalsSun Pharmaceutical IndustriesCiplaDivi's Laboratories and Abbott India are among the key stocks in focus.

A record date is the date on which a company checks its shareholder records to determine who is eligible to receive the dividend.

Torrent Pharma Announces ₹9 Final Dividend

Torrent Pharmaceuticals has recommended a final dividend of ₹9 per share on a face value of ₹5 each.

The company has fixed Friday, May 29, as the record date for the dividend payout, subject to shareholder approval.

With this, Torrent Pharma’s total dividend payout for FY26 stands at ₹38 per share.

Cipla Recommends ₹13 Dividend

Cipla has announced a final dividend of ₹13 per share.

The record date to determine eligible shareholders is Friday, June 5.

This will be the company’s only dividend payout for FY26 if approved by shareholders.

Sun Pharma Announces ₹5 Final Dividend

Sun Pharmaceutical Industries has declared a final dividend of ₹5 per share on shares with a face value of Re 1.

Earlier, the company had already paid an interim dividend of ₹11 per share.

If approved, Sun Pharma’s total dividend payout for FY26 will reach ₹16 per share. The company is yet to announce the record date and payment date for the final dividend.

Dr. Reddy’s Declares ₹8 Final Dividend

Dr. Reddy's Laboratories has fixed Friday, July 10, as the record date for its final dividend of ₹8 per share.

The dividend is subject to shareholder approval at the company’s upcoming annual general meeting.

This is the only dividend announced by the company for FY26.

Abbott India Declares Special And Final Dividend

Abbott India has announced its highest-ever dividend payout.

The company has proposed:

  • Final dividend: ₹525 per share
  • Special dividend: ₹131 per share 

This takes the total FY26 dividend payout to ₹656 per share.

The record date has been fixed as Friday, July 24, and eligible shareholders are expected to receive the payment on or after August 18, subject to approval.

Divi’s Laboratories Recommends ₹30 Dividend

Divi's Laboratories has proposed a final dividend of ₹30 per share on shares with a face value of ₹2 each.

The record date for the dividend is Friday, July 24.

The company’s annual general meeting is scheduled for August 10.

Gland Pharma Announces ₹20 Final Dividend

Gland Pharma has recommended a final dividend of ₹20 per share.

The company has fixed Tuesday, August 11, as the record date for determining eligible shareholders.

The dividend will be paid after shareholder approval at the annual general meeting.

Read More: MedPlus Health Services Share Price in Focus; Subsidiary Receives 2 Drug Licence Suspension Orders in Karnataka!

Key Pharma Dividend Record Dates To Track

CompanyDividendRecord Date
Torrent Pharma₹9May 29
Cipla₹13June 5
Dr. Reddy’s₹8July 10
Abbott India₹656 (including special dividend)July 24
Divi’s Laboratories₹30July 24
Gland Pharma₹20August 11
Sun Pharma₹5Yet to be announced

Conclusion

Pharma stocks are likely to remain in focus as companies continue rewarding shareholders with strong dividend payouts. Investors should keep an eye on upcoming record dates to remain eligible for these dividends.

For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi

Disclaimer:This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: May 25, 2026, 12:15 PM IST

Kusum Kumari

Kusum Kumari is a Content Writer with 4 years of experience in simplifying financial market concepts. Currently crafting insightful content at Angel One, She specialise in breaking down complex topics into easy-to-understand pieces, blending expertise in market fundamentals and technical analysis.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3.5 Cr+ happy customers